REVIEW
Published on 09 Jan 2025
Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs)
doi 10.3389/fphar.2024.1463520
- 374 views
12k
Total downloads
38k
Total views and downloads
Select the journal/section where you want your idea to be submitted:
REVIEW
Published on 09 Jan 2025
CASE REPORT
Published on 24 Oct 2024
MINI REVIEW
Published on 01 Oct 2024
BRIEF RESEARCH REPORT
Published on 12 Sep 2024
REVIEW
Published on 23 Aug 2024
ORIGINAL RESEARCH
Published on 19 Aug 2024
REVIEW
Published on 05 Aug 2024
REVIEW
Published on 31 Jul 2024
ORIGINAL RESEARCH
Published on 25 Jul 2024
ORIGINAL RESEARCH
Published on 24 Jul 2024
SYSTEMATIC REVIEW
Published on 15 Jul 2024
REVIEW
Published on 13 Jun 2024
Frontiers in Oncology